Ethnic differences in thiopurine methyltransferase pharmacogenetics: Evidence for allele specificity in Caucasian and Kenyan individuals

Pharmacogenetics

Volumn 9, Issue 6, 1999, Pages 773-776

  McLeod, Howard L ^a   Pritchard, Stuart C ^a   Githang'a, Jessie ^b   Indalo, Anne ^b   Ameyaw, Margaret Mary ^a   Powrie, Robert H ^a   Booth, Lynne ^a   Collie Duguid, Elaina S R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Ethnic group; Pharmacogenetics; Thiopurine methyltransferase

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENOTYPE; HUMAN; KENYA; NORMAL HUMAN; PHARMACOGENETICS; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 0033434009     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199912000-00012     Document Type: Article

References (11)

1. Ameyew MM, Collie-Duguid ESR, Powrie RH, Ofori-Adjei D, McLeod HL. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Molec Genet 1999; 8:367-570.
2. Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 1998; 129:716-718.
3. Collie-Duguid ESR, Pritchard SC, Powrie RH, Sludden J, Collier DA, Li T, McLeod HL. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999; 9:37-42.
4. de la Moureyere CSV, Debuysere H, Sabbagh N, Marez D, Vinner E, Chevalier ED, et al. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat 1998; 12:177-185.
5. Hon YY, Fessing MY, Pui C-H, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase (TPMT) gene in African Americans. Hum Molec Genet 1999; 8:371-376.
6. Lennard L, Lilleyman JS, van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990; 336:225-29.
7. McLeod HL, Miller DR, Evans WE. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341:1151.
8. McLeod HL, Lin J-S, Pui C-H, Scott EP, Evans WE. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994; 55:15-20.
9. Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Han JO, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphism. Clin Pharmacol Ther 1997; 62:60-73.
10. Snow JL, Gibson LE. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. Arch Dermatol 1995; 131:193-197.
11. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai Hung-Liang, Pui C-H, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126:608-614.